MLICM
RVNC
Metropolitan Life Insurance Company (MetLife)’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,633
| Closed | -$17.9K | – | 2224 |
|
|
2024
Q1 | $17.9K | Sell |
3,633
-1,199
| -25% | -$5.9K | ﹤0.01% | 1917 |
|
|
2023
Q4 | $42.5K | Hold |
4,832
| – | – | ﹤0.01% | 1536 |
|
|
2023
Q3 | $55.4K | Buy |
4,832
+275
| +6% | +$3.15K | ﹤0.01% | 1347 |
|
|
2023
Q2 | $115K | Buy |
4,557
+191
| +4% | +$4.83K | 0.01% | 947 |
|
|
2023
Q1 | $141K | Sell |
4,366
-626
| -13% | -$20.2K | 0.01% | 822 |
|
|
2022
Q4 | $92.2K | Buy |
4,992
+677
| +16% | +$12.5K | ﹤0.01% | 1096 |
|
|
2022
Q3 | $117K | Sell |
4,315
-459
| -10% | -$12.4K | 0.01% | 936 |
|
|
2022
Q2 | $66K | Hold |
4,774
| – | – | ﹤0.01% | 1323 |
|
|
2022
Q1 | $93.1K | Sell |
4,774
-12,182
| -72% | -$238K | ﹤0.01% | 1237 |
|
|
2021
Q4 | $277K | Sell |
16,956
-2,700
| -14% | -$44.1K | ﹤0.01% | 1789 |
|
|
2021
Q3 | $548K | Buy |
19,656
+439
| +2% | +$12.2K | 0.01% | 1398 |
|
|
2021
Q2 | $570K | Buy |
19,217
+2,257
| +13% | +$66.9K | 0.01% | 1443 |
|
|
2021
Q1 | $474K | Sell |
16,960
-602
| -3% | -$16.8K | 0.01% | 1454 |
|
|
2020
Q4 | $498K | Hold |
17,562
| – | – | 0.01% | 1353 |
|
|
2020
Q3 | $442K | Hold |
17,562
| – | – | 0.01% | 1298 |
|
|
2020
Q2 | $429K | Buy |
17,562
+1,976
| +13% | +$48.3K | 0.01% | 1327 |
|
|
2020
Q1 | $231K | Buy |
15,586
+1,299
| +9% | +$19.2K | ﹤0.01% | 1512 |
|
|
2019
Q4 | $232K | Sell |
14,287
-1,851
| -11% | -$30K | ﹤0.01% | 1810 |
|
|
2019
Q3 | $210K | Buy |
16,138
+4,702
| +41% | +$61.1K | ﹤0.01% | 1842 |
|
|
2019
Q2 | $148K | Hold |
11,436
| – | – | ﹤0.01% | 2091 |
|
|
2019
Q1 | $180K | Buy |
11,436
+561
| +5% | +$8.84K | ﹤0.01% | 1963 |
|
|
2018
Q4 | $219K | Hold |
10,875
| – | – | ﹤0.01% | 1759 |
|
|
2018
Q3 | $270K | Hold |
10,875
| – | – | ﹤0.01% | 1800 |
|
|
2018
Q2 | $299K | Buy |
10,875
+2,232
| +26% | +$61.3K | ﹤0.01% | 1668 |
|
|
2018
Q1 | $266K | Buy |
8,643
+1,106
| +15% | +$34.1K | ﹤0.01% | 1702 |
|
|
2017
Q4 | $269K | Sell |
7,537
-8,085
| -52% | -$289K | ﹤0.01% | 1717 |
|
|
2017
Q3 | $430K | Hold |
15,622
| – | – | ﹤0.01% | 1784 |
|
|
2017
Q2 | $412K | Buy |
15,622
+2,323
| +17% | +$61.3K | ﹤0.01% | 1844 |
|
|
2017
Q1 | $277K | Hold |
13,299
| – | – | ﹤0.01% | 2064 |
|
|
2016
Q4 | $275K | Hold |
13,299
| – | – | ﹤0.01% | 2149 |
|
|
2016
Q3 | $216K | Hold |
13,299
| – | – | ﹤0.01% | 2292 |
|
|
2016
Q2 | $181K | Hold |
13,299
| – | – | ﹤0.01% | 2386 |
|
|
2016
Q1 | $232K | Hold |
13,299
| – | – | ﹤0.01% | 2085 |
|
|
2015
Q4 | $454K | Buy |
13,299
+2,190
| +20% | +$74.8K | ﹤0.01% | 1680 |
|
|
2015
Q3 | $331K | Hold |
11,109
| – | – | ﹤0.01% | 1913 |
|
|
2015
Q2 | $355K | Buy |
+11,109
| New | +$355K | ﹤0.01% | 1994 |
|
|
2014
Q4 | – | Sell |
-7,262
| Closed | -$140K | – | 2675 |
|
|
2014
Q3 | $140K | Buy |
7,262
+2,823
| +64% | +$54.4K | ﹤0.01% | 2567 |
|
|
2014
Q2 | $151K | Sell |
4,439
-4,391
| -50% | -$149K | ﹤0.01% | 2649 |
|
|
2014
Q1 | $278K | Buy |
+8,830
| New | +$278K | ﹤0.01% | 2243 |
|